BETA — Beta Drugs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹12.50bn
- IN₹12.33bn
- IN₹2.96bn
- 63
- 15
- 50
- 35
Annual cashflow statement for Beta Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 120 | 160 | 343 | 411 | 488 |
| Depreciation | |||||
| Non-Cash Items | -11.1 | 0.023 | -17 | -77.3 | -129 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -62 | -42.3 | -102 | -204 | -147 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 84.1 | 186 | 296 | 234 | 309 |
| Capital Expenditures | -153 | -57.6 | -194 | -182 | -116 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.43 | -0.925 | -23.3 | -8.57 | -23.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -151 | -58.5 | -218 | -191 | -140 |
| Financing Cash Flow Items | 51.9 | -24.2 | -28 | -24.1 | -28.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 87.3 | -77.1 | -9.73 | -24.7 | -74.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 20.9 | 50.4 | 69 | 18.4 | 94.7 |